Head and neck services across the NHS manage complex cancer referrals, urgent airway assessments, swallowing disorders, thyroid nodules, endocrine dysfunction, and long-term oncology follow-up. Rising incidence of head and neck malignancies, increasing thyroid investigations, and strict Head and Neck Cancer Waiting Times targets require more than a generic system. They require a purpose-built head, neck and thyroid EHR.
The Cellma platform connects ENT clinics, oncology MDT meetings, endocrine services, speech and language therapy, radiology, pathology, and surgical units within one interoperable digital environment. Consultants, CNS teams, surgeons, endocrinologists, and therapists gain structured head and neck health records across the full patient pathway.
With national recovery priorities under NHS England and compliance expectations from NHS Digital, real-time visibility of diagnostics, cancer staging, voice assessment documentation, and thyroid function monitoring is critical. Cellma delivers a secure, scalable head, neck and thyroid EPR tailored for NHS Trusts and global healthcare organisations.
Aligned with NHS 10-Year Plan:
Cellma is purpose-built to support these goals through prevention-focused, digitally enabled, and integrated community care.
Built-in cancer staging templates support TNM classification, tumour site documentation, nodal mapping, and metastatic recording. Structured workflows ensure accurate MDT preparation and reporting for NHS cancer performance metrics.
Thyroid function dashboard allows tracking of TSH, T3, T4, antibody levels, biopsy results, medication adjustments as well as long-term endocrine follow-up.
Cellma is built for interoperability, ensuring smooth integration with national and international healthcare systems:
Fully aligned with the NHS 10 Year Plan, supporting its vision for integrated, patient-centred, and digitally enabled care over the next decade.
Built for global healthcare, enabling connected, patient-centred, and digital-first care anywhere in the world.
